** Shares of generic drug maker ERIS.NS rise as much as
9.8% to 774 rupees, on track for their best one-day pct gain
since July 1
** Co on Friday said https://bit.ly/3poPDHM it had formed a
joint venture with M. J. Biopharm and Kinedex Healthcare for
selling insulin
** The JV will source recombinant human insulin and insulin
analogs and will market them in the domestic market - Eris
** Eris will hold 70% stake in the JV
** About 269,000 ERIS shares change hands vs the 30-day avg
volume of 98,213
** ERIS shares up 21.6% this year, as of last close
(Reporting by Nallur Sethuraman in Bengaluru)
((Sethuraman.NR@thomsonreuters.com; (Within U.S.
1-646-223-8780, Outside U.S. +91 8067496031); Reuters Messaging:
nallur.sethuraman.thomsonreuters.com@reuters.net))